Table 4.
Duration of the nasal mass at presentation
| Duration (years) | Nonneoplastic | Benign | Malignant | Total (%) |
|---|---|---|---|---|
| 1–3 | 14 | 8 | 7 | 29 (76.3) |
| 4–6 | 2 | 0 | 0 | 2 (5.3) |
| 7–9 | 0 | 1 | 0 | 1 (2.6) |
| 10–12 | 0 | 6 | 0 | 6 (15.8) |
| Total (%) | 16 (62.1) | 15 (39.5) | 7 (18.4) | 38 (100) |
Duration of the nasal mass at presentation
| Duration (years) | Nonneoplastic | Benign | Malignant | Total (%) |
|---|---|---|---|---|
| 1–3 | 14 | 8 | 7 | 29 (76.3) |
| 4–6 | 2 | 0 | 0 | 2 (5.3) |
| 7–9 | 0 | 1 | 0 | 1 (2.6) |
| 10–12 | 0 | 6 | 0 | 6 (15.8) |
| Total (%) | 16 (62.1) | 15 (39.5) | 7 (18.4) | 38 (100) |